Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
QUICKKIT
Show more
Class 5: Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; In vitro gender prediction test kit; In-vitro ovulation prediction test kit for home use; Ovulation test kits; Pregnancy test kits for home use
Class 10: Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Medical test kits for diabetes monitoring for home use
Class 5 – Pharmaceuticals & supplementsClass 10 – Medical apparatus
Status timeline
- 13 Aug 2020Application filedNew Application Entered
- 4 Dec 2020Assigned to an examining attorneyAssigned To Examiner
- 7 Dec 2020Office action issuedNon-Final Action Written
- 4 Jun 2021Response to office action filedTeas Response To Office Action Received
- 15 Jul 2021Final refusal issuedFinal Refusal Mailed
- 26 Jan 2022Approved for publicationApproved For Pub - Principal Register
- 1 Mar 2022Published for oppositionPublished For Opposition
- 26 Apr 2022Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 26 Apr 2022Statement of use filedTeas Statement Of Use Received
- 25 May 2022Office action issuedNon-Final Action Written
- 7 Dec 2022Statement of use acceptedAllowed Principal Register - Sou Accepted
- 8 Dec 2022Statement of use acceptedNotice Of Acceptance Of Statement Of Use E-Mailed
- 10 Jan 2023Registered on the Principal RegisterRegistered-Principal Register
All 39 events
| 2023-01-10 | Registered-Principal Register |
| 2023-01-10 | Notice Of Registration Confirmation Emailed |
| 2022-12-08 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2022-12-07 | Su-Examiner's Amendment Written |
| 2022-12-07 | Examiners Amendment E-Mailed |
| 2022-12-07 | Notification Of Examiners Amendment E-Mailed |
| 2022-12-07 | Examiner's Amendment Entered |
| 2022-12-07 | Allowed Principal Register - Sou Accepted |
| 2022-05-25 | Non-Final Action Written |
| 2022-05-25 | Non-Final Action E-Mailed |
| 2022-05-25 | Notification Of Non-Final Action E-Mailed |
| 2022-05-05 | Case Assigned To Intent To Use Paralegal |
| 2022-05-05 | Statement Of Use Processing Complete |
| 2022-04-26 | Noa Mailed - Sou Required From Applicant |
| 2022-04-26 | Teas Statement Of Use Received |
| 2022-04-26 | Use Amendment Filed |
| 2022-03-01 | Published For Opposition |
| 2022-03-01 | Official Gazette Publication Confirmation E-Mailed |
| 2022-02-09 | Notification Of Notice Of Publication E-Mailed |
| 2022-01-27 | Law Office Publication Review Completed |
| 2022-01-26 | Examiners Amendment -Written |
| 2022-01-26 | Examiners Amendment E-Mailed |
| 2022-01-26 | Notification Of Examiners Amendment E-Mailed |
| 2022-01-26 | Examiner's Amendment Entered |
| 2022-01-26 | Approved For Pub - Principal Register |
| 2021-07-15 | Final Refusal Mailed |
| 2021-07-15 | Final Refusal E-Mailed |
| 2021-07-15 | Notification Of Final Refusal Emailed |
| 2021-07-14 | Correspondence Received In Law Office |
| 2021-07-14 | Teas/Email Correspondence Entered |
| 2021-07-13 | Assigned To Lie |
| 2021-06-04 | Teas Response To Office Action Received |
| 2020-12-07 | Non-Final Action Written |
| 2020-12-07 | Non-Final Action E-Mailed |
| 2020-12-07 | Notification Of Non-Final Action E-Mailed |
| 2020-12-04 | Assigned To Examiner |
| 2020-12-04 | Removed From Teas Plus |
| 2020-09-10 | New Application Office Supplied Data Entered |
| 2020-08-13 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; In vitro gender prediction test kit; In-vitro ovulation prediction test kit for home use; Ovulation test kits; Pregnancy test kits for home use
First use anywhere 1 Dec 2020 · First use in commerce 1 Dec 2020
Class 10 Medical apparatus
Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Medical test kits for diabetes monitoring for home use
First use anywhere 1 Dec 2020 · First use in commerce 1 Dec 2020
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 10 Jan 2023; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.